Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Scopolamine[1] Scopolamine (Scopolamine)[2] Scopolamine (Scopolamine, SCOPOLAMINE TRANDERMAL SYSTEM, SCOPOLAMINE TRANSDERMAL SYSTEM),
Scopolamine hydrobromide (Scopolamine hydrobromide, Scopolamine hydrobromide hydrate, Scopolamine hydrobromide trihydrate) 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 2 💬
2Scopolamine, atropine, edaravone and dexmedetomidine[4] Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine (Scopolamine)		[7] Atropine ,
Scopolamine (Scopolamine, SCOPOLAMINE TRANDERMAL SYSTEM, SCOPOLAMINE TRANSDERMAL SYSTEM),
Dexmedetomidine ,
Dexmedetomidine hydrochloride ,
Edaravone ,
Atropine sulfate ,
Scopolamine hydrobromide (Scopolamine hydrobromide, Scopolamine hydrobromide hydrate, Scopolamine hydrobromide trihydrate) 💬 		[8] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[16] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Hormone signaling, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2 💬